Entheon Biomedical Corp.
ENBI
CNSX
| 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 48.90K | 104.30K | 62.10K | 49.10K | 74.90K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 48.90K | 104.30K | 62.10K | 49.10K | 74.90K |
| Operating Income | -48.90K | -104.30K | -62.10K | -49.10K | -74.90K |
| Income Before Tax | -47.30K | -101.70K | -60.90K | -47.20K | -69.40K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -47.30K | -101.70K | -60.90K | -47.20K | -69.40K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -47.30K | -101.70K | -60.90K | -47.20K | -69.40K |
| EBIT | -48.90K | -104.30K | -62.10K | -49.10K | -74.90K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 0.00 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Basic EPS | 0.00 | -0.01 | 0.00 | 0.00 | -0.01 |
| EPS Diluted | 0.00 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Diluted EPS | 0.00 | -0.01 | 0.00 | 0.00 | -0.01 |
| Average Basic Shares Outstanding | 13.86M | 12.03M | 8.85M | 8.86M | 7.32M |
| Average Diluted Shares Outstanding | 13.86M | 12.03M | 8.85M | 8.86M | 7.32M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |